✦ LIBER ✦

Progression of retinopathy after change of treatment from oral antihyperglycemic agents to insulin in patients with NIDDM

✍ Scribed by Henricsson, M; Janzon, L; Groop, L.

Book ID: 125831561
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 311 KB
Volume: 121
Category: Article
ISSN: 0002-9394
DOI: 10.1016/S0002-9394(14)70466-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Insulin lispro in the treatment of patie

Insulin lispro in the treatment of patients with type 2 diabetes mellitus after oral agent failure

✍ Edward J. Bastyr III; Martin E. Johnson; Michael E. Trautmann; James H. Anderson 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 865 KB

Comparison of NovoPen 3 and syringes/via

Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents

✍ A Kadiri; A Chraibi; F Marouan; M.R Ababou; N El Guermai; A Wadjinny; A Kerfati; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 317 KB

Meta-Analysis of Randomized Controlled T

Meta-Analysis of Randomized Controlled Trials of Lixisenatide as Add On to Basal Insulin and/or Oral Antihyperglycemic Agents in Patients with Type 2 Diabetes Mellitus

✍ Goldenberg, Ronald M.; Puig-Domingo, Manuel; Fonseca, Vivian; Wang, Edward C.; L 📂 Article 📅 2013 🏛 Canadian Diabetes Association 🌐 English ⚖ 307 KB

P-7-25 Comparison of treatment of small

P-7-25 Comparison of treatment of small dose insulin or oral hypoglycemic agents on progression of micro- and macro-angiopathy in patients with non-insulin dependent diabetes mellitus

📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Treatment of Gonadal Failure in the Pati

Treatment of Gonadal Failure in the Patient With Turner Syndrome—Recognizing the Changing Trend From Oral to Transdermal Therapy

✍ Paula Didrick; Debbie LeMay; Mary Kaye Mitscher; Lori St. Dennis-Feezle; Stephan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Randomized, open-label, parallel-group e

Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: A noninferiority intensification substudy of the DURABLE trial

✍ William F. Miser; Richard Arakaki; Honghua Jiang; Jamie Scism-Bacon; Pamela W. A 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 873 KB